Difference between revisions of "Αkroprint"
Jump to navigation
Jump to search
WikiModEn2 (talk | contribs) (Add URL.) |
WikiModEn2 (talk | contribs) (Add external link.) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 14: | Line 14: | ||
|accessdate=2025-06-12 | |accessdate=2025-06-12 | ||
}}</ref> | }}</ref> | ||
| + | |||
| + | In the logo, the company writes its name as '''αkroprint'''. | ||
{{SEEALSO}} | {{SEEALSO}} | ||
| Line 19: | Line 21: | ||
{{LINKS}} | {{LINKS}} | ||
| − | |||
* {{URLwebsite|https://www.akroprint.com/|2025-06-12}} | * {{URLwebsite|https://www.akroprint.com/|2025-06-12}} | ||
* {{REFjournal | * {{REFjournal | ||
| Line 36: | Line 37: | ||
|etal=yes | |etal=yes | ||
|title=3D bioprinting for skin tissue engineering: Current status and perspectives | |title=3D bioprinting for skin tissue engineering: Current status and perspectives | ||
| − | |||
| − | |||
|journal=J Tissue Eng | |journal=J Tissue Eng | ||
|date=2021-07-13 | |date=2021-07-13 | ||
|volume=12 | |volume=12 | ||
|article=20417314211028574 | |article=20417314211028574 | ||
| − | |||
| − | |||
|url=https://journals.sagepub.com/doi/10.1177/20417314211028574 | |url=https://journals.sagepub.com/doi/10.1177/20417314211028574 | ||
| − | |||
| − | |||
|pubmedID=34345398 | |pubmedID=34345398 | ||
|pubmedCID=8283073 | |pubmedCID=8283073 | ||
|DOI=10.1177/20417314211028574 | |DOI=10.1177/20417314211028574 | ||
|accessdate=2025-06-13 | |accessdate=2025-06-13 | ||
| + | }} | ||
| + | * {{REFweb | ||
| + | |url=https://www.hegemonmedia.com/p/survey-data-shows-the-foreskin-regeneration | ||
| + | |title=Survey Data Shows The Foreskin Regeneration Market Is Over 200 Billion Dollars | ||
| + | |last=Marotta | ||
| + | |first=Brendon | ||
| + | |init= | ||
| + | |author-link=Brendon Marotta | ||
| + | |publisher=Hegemon Media | ||
| + | |date=2023-06-28 | ||
| + | |accessdate=2025-06-18 | ||
}} | }} | ||
{{REF}} | {{REF}} | ||
Latest revision as of 11:23, 18 June 2025
Αkroprint is a newly formed tissue engineering company based in Chicago, Illinois, USA. The website states that it is a (for profit) C Corporation incorporated in Delaware.
Certain members of senior management were previously associated with Foregen.
Αkroprint has announced its intent to use "3D bioprinting technologies" to develop a tissue engineered replacement foreskin for circumcised men.[1]
In the logo, the company writes its name as αkroprint.
See also
External links
Official website. Retrieved 12 June 2025- REFjournal Weng T, Zhang W, Xia Y, et al. 3D bioprinting for skin tissue engineering: Current status and perspectives. J Tissue Eng. 13 July 2021; 12: [20417314211028574]. PMID. PMC. DOI. Retrieved 13 June 2025.
- Marotta, Brendon (28 June 2023).
Survey Data Shows The Foreskin Regeneration Market Is Over 200 Billion Dollars
, Hegemon Media. Retrieved 18 June 2025.
References
- ↑ Anonymous.
About Akroprint
, Akroprint. Retrieved 12 June 2025.